Anti-17-1A monoclonal antibody 3622W94

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-17-1A monoclonal antibody 3622W94
Drug Alias Name3622W94
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionEpithelial cell adhesion molecule inhibitors
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A